C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2011
11/16/2011	EP2386576A1 Tumor-specific recognition molecules
11/16/2011	EP2386575A2 Dual specificity antibodies and methods of making and using
11/16/2011	EP2386574A2 Polypeptide variants with altered effector function
11/16/2011	EP2386318A1 Targeted biocides
11/16/2011	EP2386317A1 Methods for treating conditions associated with MASP-2 dependent complement activation
11/16/2011	EP2386316A1 Methods for treating conditions associated with MASP-2 dependent complement activation
11/16/2011	EP2386315A1 Methods for treating conditions associated with MASP-2 dependent complement activation
11/16/2011	EP2386312A2 Intrathecal and intratumoral superantigens to treat malignant disease
11/16/2011	EP2385955A2 Modified antibody compositions, methods of making and using thereof
11/16/2011	EP2029627B1 Hepatocyte growth factor (hgf) binding proteins
11/16/2011	EP1957639B1 Microginin producing proteins and nucleic acids encoding a microginin gene cluster as well as methods for creating microginins
11/16/2011	EP1654285B1 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
11/16/2011	EP1646657B1 Antibodies to cd44 vra and methods of use
11/16/2011	EP1553980B1 Nucleic acid and corresponding protein entitled 238p1b2 useful in treatment and detection of cancer
11/16/2011	EP1019439B1 Soluble single-chain t-cell receptor proteins
11/16/2011	CN1874790B Therapeutic agent for mesothelioma
11/16/2011	CN1863921B Methods for expression and purification of immunotoxins
11/16/2011	CN1789416B Human artificial chromosome containing human antibody lambda light chain
11/16/2011	CN1311820B BASB027 protein and genes from i(Moraxella Catarrhalis), antigens, antibodies, and uses
11/16/2011	CN102245773A Antibodies that specifically block the biological activity of a tumor antigen
11/16/2011	CN102245767A Immunoassay method for human CXCL1 protein
11/16/2011	CN102245641A High affinity human antibodies to PCSK9
11/16/2011	CN102245640A Anti-PD-L1 antibodies and their use to enhance T-cell function
11/16/2011	CN102245639A Antibody formulation
11/16/2011	CN102245638A Antibodies against IL-25
11/16/2011	CN102245637A Antibody against n-terminal region of beta-chain of hemoglobin
11/16/2011	CN102245208A Immunoglobulin variants and uses thereof
11/16/2011	CN102245207A Humanized anti-IL-6 antibodies
11/16/2011	CN102245198A IgE CH3 peptide vaccine
11/16/2011	CN102243239A Quick colloidal gold detection test strip for xanthomonas citri
11/16/2011	CN102242137A Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor
11/16/2011	CN102242131A Eimeria tenella apical membrane antigen 1 (AMA 1) gene and application thereof
11/16/2011	CN102242126A T1R taste receptors and genes encoding same
11/16/2011	CN102242093A Comprehensive development method of high value-added active components of eggs
11/16/2011	CN102242083A 3D protein monoclonal antibody for resisting novel duck hepatitis virus serotype I
11/16/2011	CN102242082A Monoclonal antibody of equine influenza virus nucleoprotein as well as preparation method and application thereof
11/16/2011	CN102241774A Recombinant IgE-Fc-anti EGFR single chain variable fragment fusion protein, its preparation method and its application
11/16/2011	CN102241773A Anti-myeloma cell polyclonal antibody and preparation method thereof
11/16/2011	CN102241772A Antibody and diagnostic kit
11/16/2011	CN102241771A Duck egg yolk antibody for preventing and treating virus hepatitis of duckling, and preparation method thereof
11/16/2011	CN102241770A Influenza virus M2-targeted ion channel protein VHH (Vibrio Harveyi Haemolysin) gene engineering antibody and coding gene and application thereof in preparation of anti-influenza-virus drug
11/16/2011	CN102241769A Binding molecules capable of neutralizing rabies virus and uses thereof
11/16/2011	CN102241768A Antibody against hemagglutinin of influenza A H1N1 virus
11/16/2011	CN102241758A Preparation method and medical application of cervical carcinoma associated trichina antigen antibody
11/16/2011	CN102241741A Prion protein ligands and methods of use
11/16/2011	CN101690811B Concentrated freeze-dried yolk antibody composite preparation for infectious bursal disease and preparation process thereof
11/16/2011	CN101676301B Antibody for inhibiting growth of colorectal carcinoma and its use in preparation of medicament and kit
11/16/2011	CN101654482B High specific anti-tumor monoclonal antibody
11/16/2011	CN101412697B 1-amino hydantoin derivative hapten, antigen and antibody and uses thereof
11/16/2011	CN101351477B Anti-CD19 antibodies with reduced immunogenicity
11/16/2011	CN101348525B Anti-schistosomiasis monoclonal antibody NP11-4 single-chain antibody, preparation and use thereof
11/16/2011	CN101274963B Anti-cd86 humanized monoclonal antibody
11/15/2011	US8058508 Optimizing glycan processing in plants
11/15/2011	US8058418 Polynucleotides encoding heavy and light chains of antibodies to OPGL
11/15/2011	US8058410 comprising solid phase and an affinity ligand comprising peptide bonds coupled to this solid phase; capturing and purifying Npro, Npro-mutants, Nprofusion proteins expressed as inclusion bodies under denaturing conditions or proteins with a high aggregation tendency using peptide affinity chromatography
11/15/2011	US8058407 Purification of acidic proteins using ceramic hydroxyapatite chromatography
11/15/2011	US8058406 Composition comprising antibodies to LINGO or fragments thereof
11/15/2011	US8058405 Antibodies specific for N-terminal truncated and pyroglutamate modified amyloid-beta peptides
11/15/2011	US8058404 MCM6 and MCM7 monoclonal antibodies and methods for their use in the detection of cervical disease
11/15/2011	US8058403 Antibodies to stromal cell-derived factor-1 polypeptides
11/15/2011	US8058401 Immunogenic compositions and uses thereof
11/15/2011	US8058400 Composition and method for modulating dendritic cell-t cell interaction
11/15/2011	US8058399 Multispecific reagent for selectively stimulating cell surface receptors
11/15/2011	US8058393 Microwave-assisted peptide synthesis
11/15/2011	US8058266 Methods and compositions for treatment of macular and retinal disease
11/15/2011	US8058239 HMGB1 protein inhibitorsand/or antagonists for the treatment of vascular diseases
11/15/2011	US8058062 Hybridoma producing antibodies to Lawsonia intracellularis
11/15/2011	US8058044 Deactivation of linking moieties in antibody-enzyme conjugates
11/15/2011	US8058016 Methods of using an antibody that binds to apolipoprotein e
11/15/2011	US8057801 Tick galectin
11/15/2011	US8057800 antiallergens; antibody for patient hypersensitive to peanuts or tree nuts; isolated peptide comprising an Ara h 2 T cell epitope; diagnosing or monitoring the allergenic condition in a mammal
11/15/2011	US8057799 ErbB interface peptidomimetics and methods of use thereof
11/15/2011	US8057798 Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells
11/15/2011	US8057796 Compositions and methods for the therapy and diagnosis of influenza
11/15/2011	US8057793 Anti-CD20 antibodies and fusion proteins thereof and methods of use
11/15/2011	US8057792 Use of an antibody that blocks TNF-alpha activity for treating a nerve disorder mediated by nucleus pulposus
11/15/2011	US8057791 Human antibodies specific to KDR and uses thereof
11/15/2011	CA2518569C Liquid tissue preparation from histopathologically processed biological samples, tissues and cells
11/15/2011	CA2518295C Methods of inducing the expression of bone morphogenetic proteins (bmps) and transforming growth factor-.beta. proteins (tgf-.beta.s) in cells
11/15/2011	CA2476166C Anti-cd20 antibodies and fusion proteins thereof and methods of use
11/15/2011	CA2461989C Method for treating multiple myeloma
11/15/2011	CA2422635C In vitro assay for measuring the immunogenicity of a vaccine
11/15/2011	CA2417871C Enhanced 2-keto-l-gulonic acid production
11/15/2011	CA2365196C Chlamydia antigens and corresponding dna fragments and uses thereof
11/15/2011	CA2343979C Human interleukin-b50, therapeutic uses
11/15/2011	CA2296005C Tenebrio antifreeze proteins
11/15/2011	CA2267197C Isolation and use of motoneuronotrophic factors
11/15/2011	CA2257851C Modulators of tissue regeneration
11/15/2011	CA2171761C Eotaxin: eosinophil chemotactic cytokine
11/15/2011	CA2170641C Senescent cell-derived inhibitors of dna synthesis
11/10/2011	WO2011140295A2 Modulators of notch receptor signaling and methods of use thereof
11/10/2011	WO2011140249A2 Antibodies that bind csf1r
11/10/2011	WO2011140151A1 Antibodies against epidermal growth factor receptor (egfr)
11/10/2011	WO2011140114A2 Anti-glucosaminidase passive immunization for staphylococcus aureus infections
11/10/2011	WO2011139985A1 Compositions and methods for the diagnosis and treatment of tumor
11/10/2011	WO2011139974A2 Anti-pai-1 antibodies and methods of use thereof
11/10/2011	WO2011139854A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases
11/10/2011	WO2011139853A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases
11/10/2011	WO2011139718A1 Compositions and methods useful for reducing the viscosity of protein-containing formulations
11/10/2011	WO2011139375A1 Antibodies directed against carbonic anhydrase ix and methods and uses thereof

1 ... 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 ... 1494